FDA to Release Clinical Study Reports and Possibly Select CRLs

Drug Industry Daily
A A
The FDA will begin publishing information from sponsor-produced clinical study reports, starting with documents volunteered by companies following a drug’s approval, as part of a broader agency effort to boost transparency in clinical trials.

To View This Article:

Login

Subscribe To Drug Industry Daily